REFERENCES
- Moldwin RM. The Interstitial Cystitis Survival Guide: Your Guide to the Latest Treatment Options and Coping Strategies. Oakland, CA: New Harbinger Publications; 2000.
- Jones CA, Nyberg L. Epidemiology of interstitial cystitis. Urology. 1997;49(Suppl 5A):2–9.
- Rosenberg MT, Newman DK, Page, SA. Interstitial cystitis/painful bladder syndrome: symptom recognition is key to early identification, treatment. Cleve Clin J Med. 2007;74(Suppl 3):S54–S62.
- National Center for Biotechnology Information Gene Database. FZD8 frizzled homolog 8 (Drosophila). Available at: http://www.ncbi.nlm.nih.gov/sites/pubmed?Db=gene &Cmd = retrieve& dopt=full_report&list_uids=8325. Accessed October 10, 2010.
- Keay SK, Zhang CO, Shoenfelt J, Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor-like growth factor and epidermal growth factor as unique markers for interstitial cystitis. Urology. 2001;57(6 Suppl 1):9–14.
- Nordling J, Anjum FH, Bade JJ, Primary evaluation of patients suspected of having interstitial cystitis (IC). Eur Urol. 2004;45:662–669.
- Parsons CL, Zupkas P, Parsons JK. Intravesical potassium sensitivity in patients with interstitial cystitis and urethral syndrome. Urology. 2001;57:428–432.
- Fukui Y, Kato M, Inoue Y, A metabonomic approach identifies human urinary phenylacetylglutamine as a novel marker of interstitial cystitis. J Chromatogr B Anal Technol Biomed Life Sci. 2009;877:3806–3812.
- Parsons CL, Benson G, Childs SJ, A quantitatively controlled method to prospectively study interstitial cystitis and demonstrate the efficacy of pentosan polysulfate. J Urol. 1993;150:845–848.
- Parsons CL. Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis. Urology 2005;65:45–48.
- Watson CPN. Antidepressants as adjunctive analgesics. J Pain Symptom Manage. 1994;9:392–415.
- Brookoff D. The causes and treatment and pain in interstitial cystitis. In: Sant GR, ed. Interstitial Cystitis. Philadelphia: Lippincott-Raven; 1997:177–192.
- Theoharides TC, Sant GR. Hydroyzine therapy for interstitial cystitis. Urol. 1997;49(Suppl 5A):108–109.
- Lukban JC, Whitmore K, Kellogg-Spadt S, The effect of manual physical therapy in patients diagnosed with interstitial cystitis, high-tone pelvic floor dysfunction, and sacroiliac dyfunction. Urology. 2001; 57(6 Suppl 1):121–122.
- Mendelowitz F, Moldwin R. Complementary therapies in the management of interstitial cystitis. In: Sant G, ed. Interstitial Cystitis. Philadelphia: Lippincott-Raven; 1997;235–239.
- Whitmore KE. Self-care regimens for patients with interstitial cystitis. Urol Clin North Am. 1994;21:121–130.
- Rovner E. Treatments used in women with interstitial cystitis: the Interstitial Cystitis Data Base (ICDB) study experience. Urology. 2000;56:940–945.
- Porpora MG, Picarelli A, Prosperi Porta R, Celiac disease as a cause of chronic pelvic pain, dysmenorrhea, and deep dyspareunia. Obstet Gynecol. 2002;99(5 Pt 2):937–939.
- Fall M, Lindström S. Transcutaneous electrical nerve stimulation in classic and nonulcer interstitial cystitis. Urol Clin North Am. 1994;21:131–139.
- Whitmore KE, Payne CK, Diokno AC, Lukban JC. Sacral Neuromodulation in patients with interstitial cystitis: a multicenter clinical trial. Int Urogynecol J Pelvic Floor Dysfunct. 2003;14:305–308; discussion 308–309.
- Baskin LS, Tanagho EA. Pelvic pain without pelvic organs. J Urol. 1992;147:683–686.
- Dell JR, Parsons CL. Multimodal therapy for interstitial cystitis. J Reprod Med. 2004;49(3 Suppl):243–252.
- Magni G, Moreschi C, Rigatti-Luchini S, Merskey H. Prospective study on the relationship between depressive symptoms and chronic musculoskeletal pain. Pain. 1994;56:287–297.
- Rapkin AJ, Kames LD. The pain management approach to chronic pelvic pain. J Reprod Med. 1987;32:323–327.